keyword
https://read.qxmd.com/read/38596442/fever-assessment-in-children-under-five-are-we-following-the-guidelines
#1
JOURNAL ARTICLE
Hasan M Isa, Ahmed J Isa, Murtadha A Alnasheet, Mahmood M Mansoor
BACKGROUND: Fever is a common cause of medical consultation and hospital admission, particularly among children. Recently, the United Kingdom's National Institute for Health and Care Excellence (NICE) updated its guidelines for assessing fever in children under five years of age. The efficient assessment and management of children with fever are crucial for improving patient outcomes. AIM: To evaluate fever assessment in hospitalized children and to assess its adherence with the NICE Fever in under 5s guideline...
March 9, 2024: World Journal of Clinical Pediatrics
https://read.qxmd.com/read/38592388/acetaminophen-use-during-pregnancy-and-children-s-risk-of-autism-adhd-and-intellectual-disability
#2
JOURNAL ARTICLE
Viktor H Ahlqvist, Hugo Sjöqvist, Christina Dalman, Håkan Karlsson, Olof Stephansson, Stefan Johansson, Cecilia Magnusson, Renee M Gardner, Brian K Lee
IMPORTANCE: Several studies suggest that acetaminophen (paracetamol) use during pregnancy may increase risk of neurodevelopmental disorders in children. If true, this would have substantial implications for management of pain and fever during pregnancy. OBJECTIVE: To examine the associations of acetaminophen use during pregnancy with children's risk of autism, attention-deficit/hyperactivity disorder (ADHD), and intellectual disability. DESIGN, SETTING, AND PARTICIPANTS: This nationwide cohort study with sibling control analysis included a population-based sample of 2 480 797 children born in 1995 to 2019 in Sweden, with follow-up through December 31, 2021...
April 9, 2024: JAMA
https://read.qxmd.com/read/38255358/the-dangers-of-acetaminophen-for-neurodevelopment-outweigh-scant-evidence-for-long-term-benefits
#3
REVIEW
William Parker, Lauren G Anderson, John P Jones, Rachel Anderson, Lauren Williamson, Dillan Bono-Lunn, Zacharoula Konsoula
Based on available data that include approximately 20 lines of evidence from studies in laboratory animal models, observations in humans, correlations in time, and pharmacological/toxicological considerations, it has been concluded without reasonable doubt and with no evidence to the contrary that exposure of susceptible babies and children to acetaminophen (paracetamol) induces many, if not most, cases of autism spectrum disorder (ASD). However, the relative number of cases of ASD that might be induced by acetaminophen has not yet been estimated...
December 29, 2023: Children
https://read.qxmd.com/read/38077267/efficacy-of-oral-mefenamic-acid-versus-paracetamol-as-a-prophylactic-analgesic-for-needle-pain-in-children-receiving-vaccination-a-three-arm-parallel-triple-blind-placebo-controlled-map-vac-randomized-controlled-trial
#4
JOURNAL ARTICLE
Rachna Pasi, Thirunavukkarasu Arun Babu, Vinoth Kumar Kallidoss
BACKGROUND: Needle pain due to routine vaccination is an important factor contributing to low vaccine adherence and immunization coverage. Prophylactic oral analgesics can address this important issue of needle pain related to vaccination. Paracetamol and mefenamic acid are commonly used nonsteroidal anti-inflammatory drugs for pain relief, but there is little published literature on whether the same can be used for needle pain related to vaccination. OBJECTIVES: This study was planned to compare the efficacy of oral mefenamic acid and paracetamol over placebo as a prophylactic analgesic during vaccination and prophylactic antipyretic during the post-vaccination period...
2023: Therapeutic Advances in Vaccines and Immunotherapy
https://read.qxmd.com/read/37954757/comparing-the-efficacy-of-paracetamol-ibuprofen-and-a-combination-of-the-two-drugs-in-relieving-pain-and-fever-in-the-pediatric-age-group-a-prospective-observational-study
#5
JOURNAL ARTICLE
Vivek Charde, Mukesh Sanklecha, Priyank Rajan, Ravi V Sangoi, Prashanth A, Amisha Palande, Pranav Dighe, Ruchi Kothari, Gaurav Mittal
Introduction Fever and pain are common afflictions in the pediatric population, prompting the use of paracetamol and ibuprofen as primary treatment options. However, a comprehensive understanding of their comparative efficacy, safety profiles, and potential combined use remains crucial for informed clinical decision-making. In this prospective observational study, we aimed to delve into these aspects, shedding light on the optimal management strategies for fever and pain in pediatric patients. Methodology A total of 108 children were enrolled and categorized into three groups, namely, paracetamol monotherapy, ibuprofen monotherapy, and a combination of both drugs...
October 2023: Curēus
https://read.qxmd.com/read/37891052/adverse-events-following-immunization-aefis-with-anti-meningococcus-type-b-vaccine-4cmenb-data-of-post-marketing-active-surveillance-program-apulia-region-italy-2019-2023
#6
JOURNAL ARTICLE
Pasquale Stefanizzi, Antonio Di Lorenzo, Andrea Martinelli, Lorenza Moscara, Paolo Stella, Domenica Ancona, Silvio Tafuri
The four-component recombinant-DNA anti-meningococcus B vaccine (4CMenB) has been approved by the European Medicines Agency in 2013. In Italy, 4CMenB is recommended since 2017 for use in infants under one year of age. Due to the strong evidence of increased risk of fever after administration, surveillance of adverse events following immunization (AEFIs) is a priority for 4CMenB. This cross-sectional prospective study aims at investigating 4CMenB's safety profile. The study population is represented by infants under twelve months of age vaccinated with 4CMenB in selected ambulatories in Apulia, a region in South-Eastern Italy, from October 1st, 2020, to March 31st, 2023...
October 26, 2023: Vaccine
https://read.qxmd.com/read/37791590/immediate-versus-delayed-versus-no-antibiotics-for-respiratory-infections
#7
REVIEW
Geoffrey Kp Spurling, Liz Dooley, Justin Clark, Deborah A Askew
BACKGROUND: Concerns exist regarding antibiotic prescribing for respiratory tract infections (RTIs) owing to adverse reactions, cost and antibacterial resistance. One proposed strategy to reduce antibiotic prescribing is to provide prescriptions, but to advise delay in antibiotic use with the expectation that symptoms will resolve first. This is an update of a Cochrane Review originally published in 2007, and updated in 2010, 2013 and 2017. OBJECTIVES: To evaluate the effects on duration and/or severity of clinical outcomes (pain, malaise, fever, cough and rhinorrhoea), antibiotic use, antibiotic resistance and patient satisfaction of advising a delayed prescription of antibiotics in respiratory tract infections...
October 4, 2023: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/37675390/determinants-of-caregiver-s-knowledge-and-practices-regarding-childhood-fever-management-in-a-developing-setting-a-multi-centre-cross-sectional-assessment
#8
JOURNAL ARTICLE
Ibrahim A Ogunyinka, Kazeem A Oshikoya, Kazeem B Yusuff, Yusuf Tahir, Mohammed Yahaya, Sulaiman B Adeniye, Innocent E Oforkansi
INTRODUCTION: Fever is both a sign of various diseases (chief of which are infectious in nature) and an adverse effect of certain interventions (e.g. vaccines, drugs) in the pediatric population. It elicits anxiety among caregivers and healthcare professionals alike resulting in non-evidence based practices, adverse medication administration events, waste of scarce resources and overutilization of health facilities. The determinants of these practices among caregivers in the domiciliary contexts have not been well characterized in developing settings...
2023: Frontiers in Pediatrics
https://read.qxmd.com/read/37642229/safety-and-immunogenicity-of-co-administered-meningococcal-serogroup-b-4cmenb-vaccine-a-literature-review
#9
REVIEW
Véronique Abitbol, Woo-Yun Sohn, Michael Horn, Marco Aurelio P Safadi
The four-component meningococcal serogroup B vaccine (4CMenB) is indicated for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup B. Co-administering 4CMenB with other vaccines may improve vaccine uptake provided that the safety and immunogenicity of either are not affected. Published literature on the immunogenicity and reactogenicity of 4CMenB co-administered with other routine childhood and adulthood vaccines was reviewed. From 282 publications identified, data were collated from 10 clinical studies, 3 real-world studies, and 3 reviews...
August 1, 2023: Human Vaccines & Immunotherapeutics
https://read.qxmd.com/read/37594020/paracetamol-acetaminophen-or-non-steroidal-anti-inflammatory-drugs-alone-or-combined-for-pain-relief-in-acute-otitis-media-in-children
#10
REVIEW
Joline L H de Sévaux, Roger Amj Damoiseaux, Alma C van de Pol, Vittoria Lutje, Alastair D Hay, Paul Little, Anne Gm Schilder, Roderick P Venekamp
BACKGROUND: Acute otitis media (AOM) is one of the most common childhood infectious diseases. Pain is the key symptom of AOM and central to children's and parents' experience of the illness. Because antibiotics provide only marginal benefits, analgesic treatment including paracetamol (acetaminophen) and non-steroidal anti-inflammatory drugs (NSAIDs) is regarded as the cornerstone of AOM management. This is an update of a review first published in 2016. OBJECTIVES: Our primary objective was to assess the effectiveness of paracetamol (acetaminophen) or NSAIDs, alone or combined, compared with placebo or no treatment in relieving pain in children with AOM...
August 18, 2023: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/37524553/parist-study-protocol-a-phase-i-ii-randomised-controlled-clinical-trial-to-assess-the-feasibility-safety-and-effectiveness-of-paracetamol-in-resolving-acute-kidney-injury-in-children-with-severe-malaria
#11
JOURNAL ARTICLE
George Paasi, Charles Benard Okalebo, Paul Ongodia, Cate Namayanja, Egiru Emma Isaiah Eregu, Grace Abongo, Moses Olupot, Denis Amorut, Rita Muhindo, William Okiror, Carolyne Ndila, Peter Olupot-Olupot
BACKGROUND: Acute kidney injury (AKI) has in the past been considered a rare complication of malaria in children living in high-transmission settings. More recently, however, a growing number of paediatric case series of AKI in severe malaria studies in African children have been published (Artesunate vs Quinine in the Treatment of Severe P. falciparum Malaria in African children and Fluids Expansion as Supportive Therapy trials). The Paracetamol for Acute Renal Injury in Severe Malaria Trial (PARIST) therefore, aims to assess feasibility, safety and determine the effective dose of paracetamol, which attenuates nephrotoxicity of haemoproteins, red-cell free haemoglobin and myoglobin in children with haemoglobinuric severe malaria...
July 31, 2023: BMJ Open
https://read.qxmd.com/read/36969272/discomfort-relief-after-paracetamol-administration-in-febrile-children-admitted-to-a-third-level-paediatric-emergency-department
#12
JOURNAL ARTICLE
Elena Chiappini, Matilde Bestetti, Stefano Masi, Teresa Paba, Elisabetta Venturini, Luisa Galli
BACKGROUND: international guidelines recommend treating fever in children not at a predefined body temperature limit but based on the presence of discomfort. However few studies evaluated discomfort relief after administration of antipyretics in children. METHODS: Between 1st January and 30th September 2021 a single-center prospective observational study was performed in febrile children consecutively admitted to a pediatric emergency department and treated with paracetamol orally...
2023: Frontiers in Pediatrics
https://read.qxmd.com/read/36964758/supratherapeutic-utilization-of-paracetamol-versus-ibuprofen-among-12-year-old-children-in-primary-care-in-istanbul
#13
JOURNAL ARTICLE
Dilara Bayram, Caner Vizdiklar, Volkan Aydin, Narin Akici, Omer Atac, Ahmet Akici
BACKGROUND: Paracetamol and ibuprofen are the most preferred analgesics for pain and fever management in children. Prescribing of these drugs in supratherapeutic doses may predispose to their toxicity. We aimed to compare prescribing patterns and potential overdosing of paracetamol and ibuprofen in primary care for <12-year-old children. METHODS: We analysed paracetamol- and ibuprofen-containing prescriptions (PCPs, n = 173,575 and ICPs, n = 145,655) of 1- to 11-year-old children, issued by 3:1 systematically sampled primary care physicians (n = 1,431) in Istanbul during 2016...
March 25, 2023: Family Practice
https://read.qxmd.com/read/36941046/paracetamol-use-in-pregnancy-not-as-safe-as-we-may-think
#14
JOURNAL ARTICLE
Katinka Nilsen, Anne Cathrine Staff, Stine Kleppe Krogsrud
Paracetamol is used by more than 50% of women worldwide during pregnancy; headache representing the most frequent indication. Several studies report that long-term exposure to paracetamol in utero is associated with adverse neurodevelopmental outcomes in children, indicating a dose-response effect. However, less or no risk is found to be associated with short-term exposure. Paracetamol most likely crosses the placenta through passive diffusion, and there are several possible mechanisms for how paracetamol might affect fetal brain development...
June 2023: Acta Obstetricia et Gynecologica Scandinavica
https://read.qxmd.com/read/36928608/common-selfcare-indications-of-pain-medications-in-children
#15
REVIEW
William Zempsky, John Bell, Vanessa Maria Mossali, Preeti Kachroo, Kamran Siddiqui
Pain has a multifaceted impact on individuals worldwide, affecting their physical functioning, emotional well-being, and quality of life. Children (age < 18 years) have a high prevalence of conditions associated with pain, such as toothache, headache, earache, sore throat, and respiratory tract infections, many of which may be accompanied by fever. Globally, the pharmacologic treatment of pain in pediatric patients is limited largely to nonopioid analgesics, and dosing must account for differences in age, weight, metabolism, and risk of adverse effects...
May 2023: Paediatric Drugs
https://read.qxmd.com/read/36843677/evaluation-of-the-performance-of-anganwadi-workers-in-delivering-integrated-child-development-services-in-the-rural-field-practice-area-of-a-tertiary-medical-college-in-south-india
#16
JOURNAL ARTICLE
Ipsita Debata, T S Ranganath
Background and objective To meet the overall developmental needs of children below six years, adolescent girls, and expectant and nursing mothers, the Integrated Child Development Services (ICDS) was launched on 2nd October 1975 via the network of Anganwadis. It included a range of services like supplementary nutrition, preschool education, immunization, health check-up, referral services, and nutrition and health education. The majority of Karnataka's population resides in rural areas (61.3%) and among them, children (aged zero to six years) constitute around 12...
January 2023: Curēus
https://read.qxmd.com/read/36777982/the-three-w-s-of-acetaminophen-in-children-who-why-and-which-administration-mode
#17
JOURNAL ARTICLE
Céline Thibault, Élaine Pelletier, Christina Nguyen, Evelyne D Trottier, Marie-Joëlle Doré-Bergeron, Kathryn DeKoven, Anne-Marie Roy, Nelson Piché, Jean-Francois Delisle, Caroline Morin, Julie Paquette, Niina Kleiber
Acetaminophen is one of the oldest medications commonly administered in children. Its efficacy in treating fever and pain is well accepted among clinicians. However, the available evidence supporting the use of acetaminophen's different modes of administration remains relatively scarce and poorly known. This short report summarizes the available evidence and provides a framework to guide clinicians regarding a rational use of acetaminophen in children.
2023: Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG
https://read.qxmd.com/read/36267354/have-the-prevalence-of-eczema-symptoms-increased-in-the-mexican-pediatric-population-prevalence-and-associated-factors-according-to-global-asthma-network-phase-i
#18
JOURNAL ARTICLE
Elsy Maureen Navarrete-Rodríguez, Blanca Estela Del-Río-Navarro, Nayely Reyes Noriega, Arturo Berber, Valente Mérida Palacio, Roberto García-Almaráz, Philippa Ellwood
Background: In children, atopic dermatitis or eczema is the most common inflammatory disease of the skin. According to the International Study of Asthma and Allergies in Childhood (ISAAC) Phase IIIB in Mexico, 5.8% of children and 4.9% of adolescents had eczema symptoms. In 2012, Global Asthma Network (GAN) was established to update the prevalence of eczema and estimate potential factors contributing to its development. Objective: To estimate the prevalence and associated factors for atopic eczema symptoms and diagnosis in children and adolescents according to GAN Phase I and compare the results with ISAAC Phase IIIB in Mexico...
November 2022: World Allergy Organization Journal
https://read.qxmd.com/read/35967183/the-antipyretic-effect-of-high-dose-paracetamol-versus-mefenamic-acid-in-the-treatment-of-febrile-children-a-randomized-control-trial
#19
JOURNAL ARTICLE
Amruta Loya, Mohd Saeed Siddiqui, Avinash Sangle, Vinod Ingale, Shreya Saha, Madhurasree Nelanuthala
Introduction Fever is the most common presenting symptom in children and causes distress in patients and parents. Although nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used as antipyretics, they should be reserved for pain or chronic inflammatory conditions due to safety concerns. If we can safely achieve the same antipyretic effect using a higher dose (20 mg/kg) of paracetamol, NSAIDs may be avoided for treating fever. There is a paucity of literature comparing the antipyretic effect of mefenamic acid and high-dose paracetamol...
July 2022: Curēus
https://read.qxmd.com/read/35891219/short-term-side-effects-and-sars-cov-2-infection-after-covid-19-pfizer-biontech-vaccine-in-children-aged-5-11-years-an-italian-real-world-study
#20
JOURNAL ARTICLE
Martina Capponi, Federica Pulvirenti, Bianca Laura Cinicola, Giulia Brindisi, Maria Giulia Conti, Giovanni Colaiocco, Giovanna de Castro, Cristiana Alessia Guido, Marzia Duse, Fabio Midulla, Anna Maria Zicari, Alberto Spalice
Vaccination against COVID-19 is the most effective tool to protect both the individual and the community from this potentially life-threatening infectious disease. Data from phase-3 trials showed that two doses of the BNT162b2 vaccine were safe, immunogenic, and effective against COVID-19 in children aged 5-11 years. However, no surveys in real-life settings have been carried out in this age range. Here, we conducted a cross-sectional study to evaluate the short-term adverse reactions (ARs) and the rate of protection against infection of the BNT162b2 vaccine in children aged 5-11 years by the compilation of two surveillance questionnaires conceived using Google Forms...
June 30, 2022: Vaccines
keyword
keyword
84577
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.